Skip to main content
Clinical Trials/NCT05824195
NCT05824195
Completed
Not Applicable

Evaluation of Potentially Bioactive Foods With Respect to Cardiometabolic- and Cognitive Test Variables

Lund University1 site in 1 country18 target enrollmentApril 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Subjects
Sponsor
Lund University
Enrollment
18
Locations
1
Primary Endpoint
Glucose tolerance
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The overall goal is to increase the knowledge that can be used for the development of food products with antidiabetic properties, with the aim of facilitating healthier food choices for people. More specifically, the primary aim of this project is to evaluate the effects of different varieties of quinoa on postprandial glucose tolerance and subjective appetite markers. The crossover, randomised dietary intervention study will be conducted in healthy adults.

Registry
clinicaltrials.gov
Start Date
April 15, 2023
End Date
June 3, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anne Nilsson

Associate professor

Lund University

Eligibility Criteria

Inclusion Criteria

  • BMI of 20-28
  • age between 18-40 years
  • consume a diet in accordance with Nordic Nutrition Recommendations

Exclusion Criteria

  • not vegan
  • metabolic diseases (such as diabetes)
  • Gastro intestine tract problems or irritable bowel syndrome
  • known food allergies of intolerances
  • antibiotics should not have been consumed during the last 4 weeks
  • probiotics should not have been consumed during the last 4 weeks

Outcomes

Primary Outcomes

Glucose tolerance

Time Frame: 3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes

Capillary blood glucose concentrations are measured repeatedly after test products consumed at breakfast. The postprandial incremental glucose area under the curve is used as a measure of glucose tolerance.

Secondary Outcomes

  • Subjective appetite sensations (hunger, satiety, and desire to eat)(3 hours. Fasting (time =0 minutes), 30 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes)
  • serum insulin(3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes)

Study Sites (1)

Loading locations...

Similar Trials